Life Sciences Times

Home
Life Sciences Times

Life Sciences Times covers news on Biotech, MedTech, Pharma, Public Health and other Life Sciences related news and events.

18/09/2023

SEATTLE-- Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the commercial launch of its Nautilus™ and Stingray™ platforms for advancing preclinical drug discovery. With Nautilus, researchers can now interrogate the electrophysiology of their 2D or 3D cell cultures using the latest optical measurement techniques at the push of a button. The Stingray platform allows for maturation of 3D tissues via electrical stimulation with a level of versatility currently unmatched in the industry....

SEATTLE– Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the commercial launch of its Nautilus™ and Stingray™ platforms for advancing preclinical drug discovery. With Nautilus, researchers can now interrogate the electrophysiology of their 2...

18/09/2023

TORONTO-- Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today that as part of its strategic plan to evolve into a forward-integrated biopharmaceutical company, Brian O’Callaghan has been appointed chief executive officer (CEO) and member of the board of directors. Mr. O’Callaghan, who most recently served as CEO of ObsEva SA has extensive experience in the biotech, pharmaceutical and clinical research organization industries with previous responsibilities managing multiple businesses and programs across many therapeutic areas, from concept through to commercialization....

TORONTO– Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today that as part of its strategic plan to evolve into a forward-integrated biopharmaceutical company, Brian O’Callaghan has been appointed chief executive off...

18/09/2023

DALLAS-- Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted and transformative cancer therapies using its proprietary AI and machine learning (ML) platform, RADR®, with multiple clinical stage drug programs, today announced that the United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for LP-284. LP-284 is being developed for the treatment of relapsed or refractory non-Hodgkin’s lymphoma (NHL), including mantle cell lymphoma (MCL) and double hit lymphoma (DHL) and other high-grade B-cell lymphomas (HGBL)....

DALLAS– Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted and transformative cancer therapies using its proprietary AI and machine learning (ML) platform, RADR®, with multiple clinical stage drug programs, today announced that the United States Food a...

07/09/2023

ISSY LES MOULINEAUX, France & LAVAL, Quebec-- Cerba HealthCare, a leading global player in medical diagnosis, today announced it has acquired CIRION BIOPHARMA RESEARCH INC (CIRION), a Canadian-controlled private company highly recognized for its integrated bioanalytical and global central laboratory services. CIRION, a leading contract research organization has been operating global clinical trials over 30 years. Besides its bioanalytical capabilities highly specialized in Biosimilars/Biologics development including PKPD and Immunogenicity testing, it offers central lab full solutions with fast start-up capabilities for managing international multi-center clinical studies and supports specimen management for complex development projects....

ISSY LES MOULINEAUX, France & LAVAL, Quebec– Cerba HealthCare, a leading global player in medical diagnosis, today announced it has acquired CIRION BIOPHARMA RESEARCH INC (CIRION), a Canadian-controlled private company highly recognized for its integrated bioanalytical and global central laborator...

07/09/2023

FRANKFURT, Germany-- Fraport AG has announced the procurement decision in favor of Bruker for the provision of up to 220 DE-tector™ flex explosives and narcotics trace detectors to support their airport security measures. The installations are planned over a multi-year period from 2023 to 2027 to modernize the screening of passengers at Germany’s busiest airport FRA. The next-generation, high-performance Bruker DE-tector flex systems are intended to replace earlier-generation Bruker ETD systems at Frankfurt airport....

FRANKFURT, Germany– Fraport AG has announced the procurement decision in favor of Bruker for the provision of up to 220 DE-tector™ flex explosives and narcotics trace detectors to support their airport security measures. The installations are planned over a multi-year period from 2023 to 2027 to...

07/09/2023

BOSTON & SAN DIEGO-- Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) to advance precision neuromedicines, today announced the appointment of Cheryl Gault as Chief Operating Officer and Wendy Young, Ph.D., as a member of its Scientific Advisory Board. "Cheryl brings great experience in leading corporate operations, development and strategy, which will position Rapport well to make strides in our ongoing clinical programs in seizure and psychiatric disorders and further the development of our portfolio strategy,” said Abraham Ceesay, Chief Executive Officer of Rapport....

BOSTON & SAN DIEGO– Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) to advance precision neuromedicines, today announced the appointment of Cheryl Gault as Chief Operating Officer and Wendy Young, Ph.D., as a member o...

06/09/2023

RESTON, Va.-- Comstock Holding Companies, Inc. (Nasdaq: CHCI) (“Comstock” or the “Company”), a leading asset manager, developer, and operator of mixed-use and transit-oriented properties in the Washington, D.C. region, announced today that David P. Paul has been appointed to its Board of Directors and will serve an initial term that expires at the Company’s 2024 Annual Meeting of Stockholders. Mr. Paul is a seasoned real estate executive and former President and Chief Operating Officer of JBG SMITH (NYSE: JBGS), a publicly traded real estate investment trust....

RESTON, Va.– Comstock Holding Companies, Inc. (Nasdaq: CHCI) (“Comstock” or the “Company”), a leading asset manager, developer, and operator of mixed-use and transit-oriented properties in the Washington, D.C. region, announced today that David P. Paul has been appointed to its Board of Di...

06/09/2023

CLEVELAND-- Medical device and technology company Lazurite® has named Julia Greenspan Director of Sales Operations. In this position, she is responsible for leading sales operations, including the sales process and funnel management, sales support and training, and customer training on use and maintenance of the ArthroFree® Surgical Camera System, the first FDA-cleared wireless surgical camera for arthroscopy and general endoscopy....

CLEVELAND– Medical device and technology company Lazurite® has named Julia Greenspan Director of Sales Operations. In this position, she is responsible for leading sales operations, including the sales process and funnel management, sales support and training, and customer training on use and mai...

06/09/2023

CRYSTAL LAKE, Ill.-- AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. “We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah’s extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry for companies like Novartis and Bristol-Myers Squibb, makes her an important addition to Aptar’s Board of Directors,” said Stephan B....

CRYSTAL LAKE, Ill.– AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of...

06/09/2023

SAN DIEGO-- Tentarix Biotherapeutics, a biotechnology company focused on leveraging its proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics, today announced it has raised $35 million in a Series B financing led by Amplitude Ventures with participation from Gilead Sciences, Inc., and founding investors Versant Ventures and Samsara BioCapital. “With the support of this group of industry-leading investors, we are well-capitalized to continue advancing our promising Tentacles™ platform,” said President and CEO Paul Grayson....

SAN DIEGO– Tentarix Biotherapeutics, a biotechnology company focused on leveraging its proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics, today announced it has raised $35 million in a Series B financing led by Amplitude Ventures with part...

06/09/2023

CAMBRIDGE, MA—The Kempner Institute for the Study of Natural and Artificial Intelligence at Harvard University announces the appointment of Dr. Kanaka Rajan, the first faculty member hired within the recently launched Kempner Institute. As a founding faculty member at the Kempner, Dr. Rajan will serve as an institute investigator. She will also have a dual appointment, serving as a member of the faculty in the Department of Neurobiology at Harvard Medical School....

06/09/2023

ALBUQUERQUE, N.M.-- BioFlyte, a bioaerosol surveillance firm with a disruptive new class of fieldable biological threat collection, detection, and identification solutions, today announced the appointment of Daniel (Dan) Gussin as Vice President of Product. In this role, Gussin will lead the company’s product development roadmap and commercialization efforts to ensure that its evolving capabilities continue to exceed customer expectations. Gussin has more than two decades of proven experience leading product development efforts within the diagnostics and life sciences industries and brings both technical and leadership skills to BioFlyte....

ALBUQUERQUE, N.M.– BioFlyte, a bioaerosol surveillance firm with a disruptive new class of fieldable biological threat collection, detection, and identification solutions, today announced the appointment of Daniel (Dan) Gussin as Vice President of Product. In this role, Gussin will lead the compan...

06/09/2023

SAN JOSE, Calif.-- Panasas®, the data engine for innovation, today announced the appointment of Ken Claffey as its new Chief Executive Officer. With Claffey’s robust background and expertise in high-performance computing (HPC), cloud, and enterprise data storage technologies, the company is poised to seize new market opportunities under his leadership. Claffey replaces Tom Shea, who will remain on the Panasas executive leadership team as Chief Operating Officer....

SAN JOSE, Calif.– Panasas®, the data engine for innovation, today announced the appointment of Ken Claffey as its new Chief Executive Officer. With Claffey’s robust background and expertise in high-performance computing (HPC), cloud, and enterprise data storage technologies, the company is pois...

06/09/2023

CAMBRIDGE, England & BOSTON-- Apollo Therapeutics (“Apollo” or “the Company”), a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines through a hub-and-spoke approach, today announces the close of $226.5 million in a Series C financing led by lead investor Patient Square Capital. Highlights: $226.5m million raised. Financing led by Patient Square Capital. Participation by multiple new investors including M&G plc and two of the largest US public pension plans, along with existing investor Rock Springs Capital....

CAMBRIDGE, England & BOSTON– Apollo Therapeutics (“Apollo” or “the Company”), a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines through a hub-and-spoke approach, today announces the close of $226.5 million in a Series C financing led b...

06/09/2023

CHARLOTTESVILLE, Va.-- Amy Christensen, Partner and Co-Head of Healthcare at The Vistria Group, has been appointed Chairperson of the Healthcare Private Equity Association (HCPEA), a nonprofit trade association focused on convening and supporting the healthcare investment community. Christensen previously served as Vice Chairperson and succeeded Alex Albert, Founding Partner, Patient Square Capital, effective July 1, 2023. As prior Chairperson, Albert now leads HCPEA’s strategic plan initiative, carving the path for future investment leaders looking to make positive change in healthcare....

CHARLOTTESVILLE, Va.– Amy Christensen, Partner and Co-Head of Healthcare at The Vistria Group, has been appointed Chairperson of the Healthcare Private Equity Association (HCPEA), a nonprofit trade association focused on convening and supporting the healthcare investment community. Christensen pre...

28/08/2023

CINCINNATI-- Element Materials Technology (Element), a global leader in testing, inspection and certification (TIC) services, announces an $8m expansion in the Cincinnati region, with a new functional support center for colleagues in North America at The Landings in Blue Ash, Ohio. The 21,525 square-feet of office space located on the fourth floor of the Landings II, a Class A building, will support colleague growth as the business expands....

CINCINNATI– Element Materials Technology (Element), a global leader in testing, inspection and certification (TIC) services, announces an $8m expansion in the Cincinnati region, with a new functional support center for colleagues in North America at The Landings in Blue Ash, Ohio. The 21,525 squar...

28/08/2023

SEATTLE-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for discovery and translational research, today announced that Todd Garland has been appointed Chief Commercial Officer, effective August 28, 2023. Mr. Garland is a senior executive with more than 25 years of experience in healthcare and life sciences technologies that serve customers in the discovery, translational and clinical markets. Most recently Mr....

SEATTLE– NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for discovery and translational research, today announced that Todd Garland has been appointed Chief Commercial Officer, effective August 28, 2023. Mr. Garland is a senior executive with more than 25 years of ex...

28/08/2023

CHICAGO-- GE HealthCare (Nasdaq: GEHC) today announced the launch of Vscan Air SL – a handheld, wireless ultrasound imaging system designed for rapid cardiac and vascular assessments at the point of care to help clinicians accelerate diagnoses and treatment decisions. The latest addition to the Vscan product suite, Vscan Air SL features GE HealthCare’s proprietary SignalMax and XDclear technology that provide high levels of pe*******on, resolution, and sensitivity in imaging performance with an industry-leading single crystal transducer technology....

CHICAGO– GE HealthCare (Nasdaq: GEHC) today announced the launch of Vscan Air SL – a handheld, wireless ultrasound imaging system designed for rapid cardiac and vascular assessments at the point of care to help clinicians accelerate diagnoses and treatment decisions. The latest addition to the V...

28/08/2023

CAMBRIDGE, England & WALTHAM, Mass.-- Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, announced today that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (‘Danaher’) will acquire all of the outstanding shares of Abcam for $24.00 per share in cash (the ‘Transaction’)....

CAMBRIDGE, England & WALTHAM, Mass.– Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, announced today that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (‘Dan...

28/08/2023

NEW YORK-- Nectar Life Sciences, the trusted health technology company behind the first hybrid, vertically-integrated allergy care platform, today announced the grand opening of its flagship Nectar Allergy Center, located in New York City. The clinic expands Nectar’s platform from virtual care offerings to the physical realm, creating a hybrid model that treats both adults and children wherever it’s convenient for them....

NEW YORK– Nectar Life Sciences, the trusted health technology company behind the first hybrid, vertically-integrated allergy care platform, today announced the grand opening of its flagship Nectar Allergy Center, located in New York City. The clinic expands Nectar’s platform from virtual care of...

28/08/2023

SAN FRANCISCO-- Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced the appointment of Jim Stuart as chief commercial officer and Jay Wohlgemuth, M.D., to the board of directors. “We’re delighted to welcome Jim to our growing team,” said Brad Murray, co-founder and CEO of Delve Bio. “His track record of driving commercial success in molecular diagnostics gives us full confidence in his ability to increase physician and patient access to our mNGS test.”...

SAN FRANCISCO– Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced the appointment of Jim Stuart as chief commercial officer and Jay Wohlgemuth, M.D., to the board of directors. “We’re delighted to welcome Jim to our growing team,” s...

28/08/2023

BOSTON-- i2o Therapeutics, Inc. today announced the appointment of Kurt Graves as Chairman, President and CEO. He was previously Executive Chairman of the Board, a position he held since August 2021. Mr. Graves succeeds i2o co-founder and CEO Ravi Srinivasan, Ph.D., who is pursuing other leadership opportunities within the life sciences field. While i2o has been actively advancing the ionic liquids technology in pre-clinical work on its lead GLP-1 asset, in parallel the company has completed a series of corporate and strategic transactions including:...

BOSTON– i2o Therapeutics, Inc. today announced the appointment of Kurt Graves as Chairman, President and CEO. He was previously Executive Chairman of the Board, a position he held since August 2021. Mr. Graves succeeds i2o co-founder and CEO Ravi Srinivasan, Ph.D., who is pursuing other leadership...

28/08/2023

BURLINGAME, Calif.-- Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” and “the Company”), a diversified holding company with a portfolio of royalties and other healthcare assets, today announced the appointment of Stephen Basso as its Chief Financial Officer, effective August 21, 2023. “We are excited to welcome Stephen to our executive leadership team and believe the Company will benefit greatly from his background and experience,” said Pavel Raifeld, Chief Executive Officer of Innoviva....

BURLINGAME, Calif.– Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” and “the Company”), a diversified holding company with a portfolio of royalties and other healthcare assets, today announced the appointment of Stephen Basso as its Chief Financial Officer, effective August 21, 2023. “We are e...

28/08/2023

TORONTO & LONDON-- Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, and Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (“Small Pharma”), a U.K.-based biotechnology company focused on short-duration psychedelic therapies for mental health conditions, today announced that they have entered into a definitive arrangement agreement (the “Agreement”) pursuant to which Cybin will acquire all of Small Pharma’s issued and outstanding securities in an all-share transaction pursuant to a plan of arrangement (the “Transaction”)....

TORONTO & LONDON– Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, and Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (“Small Pharm...

28/08/2023

MONMOUTH JUNCTION, N.J.-- Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on ADHD, pain and neurological disorders, today announced that the company has been awarded a grant expected to provide up to $16.6M over five years from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH). Through the Helping to End Addiction Long-term® Initiative (NIH HEAL Initiative®), NIH has awarded grants to fund the optimization of new therapies to prevent and treat opioid use disorder (OUD)....

MONMOUTH JUNCTION, N.J.– Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on ADHD, pain and neurological disorders, today announced that the company has been awarded a grant expected to provide up to $16.6M over five years from the National Institute on Drug Abuse (NI...

24/08/2023

DAVIS, Calif.-- Botanical Solution Inc. (BSI), the multiple award-winning innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured an additional $7 million investment. Following the announcement of a partnership with Croda to accelerate the production of a green, high quality and pharma spec QS-21 at kilogram scale under GMP standards, the Company has gone further in demonstrating, through internal programs and collaboration with big pharma companies, that its product is biochemically comparable and as immunogenic as the traditional QS-21, obtained from very old soapbark trees that grow predominantly in Chile....

DAVIS, Calif.– Botanical Solution Inc. (BSI), the multiple award-winning innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured an additional $7 million investment. Following the announcement of a partnership with Croda to accelerate t...

24/08/2023

RONKONKOMA, N.Y.-- Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce OneShot™ single-use filling needles from Overlook Industries, a manufacturer of single-use filling needles and molded fluid path assemblies for pharma and biopharma fill-finish machinery. OneShot™ filling needles are available in a variety of styles and sizes as OEM replacements for the most popular brands including Bausch + Ströbel, IMA, Pall, Inova and Syntegon....

RONKONKOMA, N.Y.– Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce OneShot™ single-use filling needles from Overlook Industries, a manufacturer of single-use filling needles and molded fluid path assemblies for pharma...

16/08/2023

MENLO PARK, Calif.-- HALO Precision Diagnostics (“HALO”), the leader in early disease detection using precision diagnostics, today announced the appointment of John Craighead, Ph.D., as chief operating officer and chief financial officer. “John’s deep life science industry experience and business and financial acumen will serve HALO well as we pursue our life-saving mission,” said Michael Uhl, HALO chief executive officer. “Together we will make personalized medicine more accessible and affordable, transforming how patients and their doctors get ahead and stay ahead of deadly diseases.”...

MENLO PARK, Calif.– HALO Precision Diagnostics (“HALO”), the leader in early disease detection using precision diagnostics, today announced the appointment of John Craighead, Ph.D., as chief operating officer and chief financial officer. “John’s deep life science industry experience and bu...

15/08/2023

CULVER CITY, Calif.-- Taking a people-first approach, BioscienceLA, the ecosystem accelerator for life sciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors. In 2022, the National Institutes of Health, the largest public funder of biomedical research worldwide, awarded $1.7 billion – more than 30 percent of its total funding across California – to institutions and companies in Greater Los Angeles....

CULVER CITY, Calif.– Taking a people-first approach, BioscienceLA, the ecosystem accelerator for life sciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors. In 2022, the National Institutes of Health, the large...

15/08/2023

BOSTON-- Boston Micro Fabrication (BMF), a leader in advanced manufacturing solutions for ultra-high precision applications, announced it is entering the dental market with the launch of UltraThineer™, the world's thinnest cosmetic dental veneer. The new 3D-printed veneers use projection micro stereolithography (PµSL), a technology that custom-manufactures veneers that are three-times thinner than traditional veneers and require significantly less preparation for dental professionals, allowing preservation of the patient’s enamel with less reduction....

BOSTON– Boston Micro Fabrication (BMF), a leader in advanced manufacturing solutions for ultra-high precision applications, announced it is entering the dental market with the launch of UltraThineer™, the world’s thinnest cosmetic dental veneer. The new 3D-printed veneers use projection micro ...

Address

1344 Main Street

Website

http://www.BLSTimes.com/

Alerts

Be the first to know and let us send you an email when Life Sciences Times posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Life Sciences Times:

Shortcuts

Address
Alerts
Contact The Business
Claim ownership or report listing
Want your business to be the top-listed Media Company?

Country:

City:

18/09/2023

18/09/2023

18/09/2023

07/09/2023

07/09/2023

07/09/2023

06/09/2023

06/09/2023

06/09/2023

06/09/2023

06/09/2023

06/09/2023

06/09/2023

06/09/2023

06/09/2023

28/08/2023

28/08/2023

28/08/2023

28/08/2023

28/08/2023

28/08/2023

28/08/2023

28/08/2023

28/08/2023

28/08/2023

24/08/2023

24/08/2023

16/08/2023

15/08/2023

15/08/2023

Address

Website

Alerts

Contact The Business

Shortcuts

Share